Dementia Flashcards
Definition of dementia
Significant cognitive impairment in at least one area
Acquired impairment - significant decline from baseline
Cognitive deficits must interfere with ADLs
Exclude other causes eg delirium
Areas where cognitive impairment can occur
Learning and memory Language Executive functioning Complex attention Perceptual motor function Social cognition
What is mild cognitive impairment
Impaired cognition without affecting function
How many people progress from mild cognitive impairment to dementia
10-15% per year
Predictors for conversion to dementia from mild cognitive impairment
Age Hypertension Lower education Verbal and executive dysfunction Depression Hippocampal size Apo E4 MRI changes CSF - elevated Tau
Most common cause of dementia
Alzheimers disease
Pathogenesis of Alzheimers disease
Neuritic plaques containing amyloid beta form outside cells and accumulate in blood vessels
Neurofibrillary tangles of tau protein form inside cells and impair axon transport
Spread from medial temporal lobe to temporal neocortex to other parts of cortex
Genetics of Alzheimers
Apo E gene
- found on chromosome 19
- if have one allele - increased risk of AD by 2-3x
- if have two alleles - increased risk of AD by 8-12x
Familial AD (early onset)
- APP gene on chromosome 21, implicated in Downs syndrome dementia
- Presenilin 1 and 2 mutations - can’t cleave amyloid
Risk factors for Alzheimers
ApoE4 allele Age (strongest risk factor) Family history Female Type 2 diabetes Obesity Increased homocysteine, cholesterol and blood pressure Less physical activity
Clinical features of Alzheimers
Episodic memory loss
Language - anomia, empty speech, logopenic aphasia
Visuospatial deficit
Executive function
Disorientation, agraphia, acalculia
Apraxia - difficulty performing learnt tasks
Non cognitive
- depression
- apathy
- delusions - Capgras
- olfactory dysfunction
- agitation, paranoia
Diagnosis of Alzheimers
Involve 2 domains of cognitive impairment
MRI - hippocampal atrophy, parietal atrophy, ventricular enlargement
FDG-PET - parieto-temporal hypometabolism
C-PIB-PET - accumulation of cortical fibrillar amyloid
CSF - low amyloid beta levels, high level of phosphorylated Tau
Pharmacological options for Alzheimers
Acetylcholinesterase inhibitors (Donepezil) - increase levels of acetylcholine, used in mild-moderate AD
NMDA receptor antagonist (Memantine) - reduces excitotoxicity of glutamate on hippocampus, benefit in moderate-severe AD
Side effects of acetylcholinesterase inhibitors
Diarrhoea Nausea vomiting Cramps CI in asthma, peptic ulcer disease, conduction defects
Side effects of memantine
Dizziness
Confusion
Drowsiness